Gill Harjit, an insider at Resmed Inc (RMD), sold 9,867 shares of the company on November 10, 2025, at a price of $250.10 per share, resulting in a total transaction value of $2.47 million. Following this sale, Harjit retains an equal number of shares in the company.
Resmed, headquartered in San Diego, California, specializes in digital health and cloud-connected medical devices aimed at diagnosing and managing respiratory disorders. The company employs approximately 10,600 full-time staff and operates in two segments: Sleep and Breathing Health and Residential Care Software.
As of November 13, 2025, Resmed boasts a market capitalization of $36.9 billion, a P/E ratio of 25.69, and an EPS of 9.77. The company is also known for its cloud-based software applications designed to enhance patient care and quality of life. Upcoming earnings are scheduled for April 20, 2026, with an estimated EPS of $2.79 and revenue of $1.4 billion.
Insider transactions, including sales like this one, are reported to the SEC and can provide insights into executive sentiment. However, such transactions should be viewed in the context of broader market trends and other financial indicators. Investors are encouraged to consider patterns of insider activity across multiple individuals and time frames rather than isolated transactions.